Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Biopharmaceutical Excipients Companies

At the forefront of drug formulation, Biopharmaceutical Excipients companies specialize in providing critical components for pharmaceutical products. Focused on excipient development, they offer safe and effective ingredients that enhance drug stability, delivery, and absorption, contributing to the overall efficacy and safety of biopharmaceuticals.

Biopharmaceutical Excipients Key Companies

Latest Biopharmaceutical Excipients Companies Update:

Ashland Introduces Polyplasdone Plus, a Multifunctional Superdisintegrant: In June 2023, Ashland introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant that combines the functionalities of a glidant and a lubricant in a single excipient.

Lubrizol Life Science Health Wins Award for Apisolex Polymer Excipient: In October 2023, Lubrizol Life Science Health was awarded the Finished Formulation Award at CPhI Barcelona for its Apisolex Polymer solubilizing excipient.

DFE Pharma Expands Dry Powder Inhalation (DPI) Portfolio: In July 2022, DFE Pharma announced the launch of Lactohale 400, a new excipient specifically designed for dry powder inhalation (DPI) formulations.

Evonik Industries Invests in Expansion of Excipient Production Capacity: In September 2023, Evonik Industries announced plans to invest €200 million to expand its production capacity for cellulose-based excipients at its site in Antwerp, Belgium.

List of Biopharmaceutical Excipients Key companies in the market

Merck KGaA (Germany)

Colorcon (BPSI Holdings Inc)(.S)

BASF SE(Germany)

Associated British Foods plc (UK)

Signet Excipients Pvt. Ltd (IMCD) (Netherlands)

Sigachi Industries Limited (India)

Spectrum Chemical Manufacturing Corp. (US)

Roquette Frères (France)

Clariant (Switzerland)

DFE Pharma (Germany)

Rettenmaier & SöhneGmbh + Co Kg (Germany)

Evonik Industries AG (Germany)

Biopharmaceutical Excipients Market Highlights:

Biopharmaceutical Excipients Market Size

Biopharmaceutical Excipients Market Trends

Biopharmaceutical Excipients Market Analysis

Biopharmaceutical Excipients Market Share

Biopharmaceutical Excipients Market Highlights:

Biopharmaceutical Excipients Market Trends

Biopharmaceutical Excipients Market Analysis

Biopharmaceutical Excipients Market Share

Biopharmaceutical Excipients Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.